130 related articles for article (PubMed ID: 36720449)
21. Recent advances in iron oxide nanoparticles for brain cancer theranostics: from
Sheervalilou R; Shirvaliloo M; Sargazi S; Ghaznavi H
Expert Opin Drug Deliv; 2021 Jul; 18(7):949-977. PubMed ID: 33567919
[No Abstract] [Full Text] [Related]
22. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.
Erdal E; Demirbilek M; Yeh Y; Akbal Ö; Ruff L; Bozkurt D; Cabuk A; Senel Y; Gumuskaya B; Algın O; Colak S; Esener S; Denkbas EB
Appl Biochem Biotechnol; 2018 May; 185(1):91-113. PubMed ID: 29082480
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor is a potential biomarker for poor cetuximab response in tongue cancer cells.
Ansell A; Jedlinski A; Johansson AC; Roberg K
J Oral Pathol Med; 2016 Jan; 45(1):9-16. PubMed ID: 25677871
[TBL] [Abstract][Full Text] [Related]
24. Photo-fluorescent and magnetic properties of iron oxide nanoparticles for biomedical applications.
Shi D; Sadat ME; Dunn AW; Mast DB
Nanoscale; 2015 May; 7(18):8209-32. PubMed ID: 25899408
[TBL] [Abstract][Full Text] [Related]
25. Quantification and biodistribution of iron oxide nanoparticles in the primary clearance organs of mice using T
Zhang J; Ring HL; Hurley KR; Shao Q; Carlson CS; Idiyatullin D; Manuchehrabadi N; Hoopes PJ; Haynes CL; Bischof JC; Garwood M
Magn Reson Med; 2017 Aug; 78(2):702-712. PubMed ID: 27667655
[TBL] [Abstract][Full Text] [Related]
26. Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy.
Sadhukha T; Wiedmann TS; Panyam J
Biomaterials; 2013 Jul; 34(21):5163-71. PubMed ID: 23591395
[TBL] [Abstract][Full Text] [Related]
27. Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles.
Kaluzova M; Bouras A; Machaidze R; Hadjipanayis CG
Oncotarget; 2015 Apr; 6(11):8788-806. PubMed ID: 25871395
[TBL] [Abstract][Full Text] [Related]
28. Specific targeting of nasopharyngeal carcinoma cell line CNE1 by C225-conjugated ultrasmall superparamagnetic iron oxide particles with magnetic resonance imaging.
Liu D; Chen C; Hu G; Mei Q; Qiu H; Long G; Hu G
Acta Biochim Biophys Sin (Shanghai); 2011 Apr; 43(4):301-6. PubMed ID: 21345916
[TBL] [Abstract][Full Text] [Related]
29. Anti-FGFR1 aptamer-tagged superparamagnetic conjugates for anticancer hyperthermia therapy.
Jurek PM; Zabłocki K; Waśko U; Mazurek MP; Otlewski J; Jeleń F
Int J Nanomedicine; 2017; 12():2941-2950. PubMed ID: 28442904
[TBL] [Abstract][Full Text] [Related]
30. Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain.
Israel LL; Galstyan A; Holler E; Ljubimova JY
J Control Release; 2020 Apr; 320():45-62. PubMed ID: 31923537
[TBL] [Abstract][Full Text] [Related]
31. One-pot preparation of hyaluronic acid-coated iron oxide nanoparticles for magnetic hyperthermia therapy and targeting CD44-overexpressing cancer cells.
Soleymani M; Velashjerdi M; Shaterabadi Z; Barati A
Carbohydr Polym; 2020 Jun; 237():116130. PubMed ID: 32241421
[TBL] [Abstract][Full Text] [Related]
32. Optimization and Design of Magnetic Ferrite Nanoparticles with Uniform Tumor Distribution for Highly Sensitive MRI/MPI Performance and Improved Magnetic Hyperthermia Therapy.
Du Y; Liu X; Liang Q; Liang XJ; Tian J
Nano Lett; 2019 Jun; 19(6):3618-3626. PubMed ID: 31074627
[TBL] [Abstract][Full Text] [Related]
33. Ultrashort echo time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor models.
Wang L; Zhong X; Qian W; Huang J; Cao Z; Yu Q; Lipowska M; Lin R; Wang A; Yang L; Mao H
J Magn Reson Imaging; 2014 Nov; 40(5):1071-81. PubMed ID: 25485347
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and characterisation of iron oxide nanoparticles conjugated with epidermal growth factor receptor (EGFR) monoclonal antibody as MRI contrast agent for cancer detection.
Salehnia Z; Shahbazi-Gahrouei D; Akbarzadeh A; Baradaran B; Farajnia S; Naghibi M
IET Nanobiotechnol; 2019 Jun; 13(4):400-406. PubMed ID: 31171745
[TBL] [Abstract][Full Text] [Related]
35. Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors.
Shevtsov MA; Nikolaev BP; Yakovleva LY; Marchenko YY; Dobrodumov AV; Mikhrina AL; Martynova MG; Bystrova OA; Yakovenko IV; Ischenko AM
Int J Nanomedicine; 2014; 9():273-87. PubMed ID: 24421639
[TBL] [Abstract][Full Text] [Related]
36. Current state and future applications of active targeting in malignancies using superparamagnetic iron oxide nanoparticles.
Islam T; Josephson L
Cancer Biomark; 2009; 5(2):99-107. PubMed ID: 19414927
[TBL] [Abstract][Full Text] [Related]
37. Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines.
Oshima G; Wennerberg J; Yamatodani T; Kjellén E; Mineta H; Johnsson A; Ekblad L
J Cancer Res Clin Oncol; 2012 Mar; 138(3):491-9. PubMed ID: 22193422
[TBL] [Abstract][Full Text] [Related]
38. Analyzing the mechanisms of iron oxide nanoparticles interactions with cells: A road from failure to success in clinical applications.
Frtús A; Smolková B; Uzhytchak M; Lunova M; Jirsa M; Kubinová Š; Dejneka A; Lunov O
J Control Release; 2020 Dec; 328():59-77. PubMed ID: 32860925
[TBL] [Abstract][Full Text] [Related]
39. DMSA-coated cubic iron oxide nanoparticles as potential therapeutic agents.
Çitoğlu S; Coşkun ÖD; Tung LD; Onur MA; Thanh NTK
Nanomedicine (Lond); 2021 May; 16(11):925-941. PubMed ID: 34015971
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
